Abstract
In clinical practice, we found that some primary gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma had different prognosis. This study aimed to explore the role of IGH rearrangement, p53 and ATM gene variations in the assessment of prognosis in primary gastrointestinal MALT lymphoma. In 50 cases of primary gastrointestinal MALT lymphoma (1) IGH arrangement was found in 59.5 % of patients with primary gastrointestinal MALT lymphoma; IGH arrangement was found in 48.4 % of patients with primary gastrointestinal MALT lymphoma at stage I–II and in 90.9 % of patients at stage III–IV (χ 2 = 6.093, p < 0.05). Average survival time in patients with IGH rearrangement was 16.39 months, being shorter than that in patients with non-IGH rearrangement (38.13 months) (t = 3.239, p < 0.01). (2) p53 gene deletion was found in 31.0 % of patients with primary gastrointestinal MALT lymphoma; p53 gene deletion was found in 22.6 % of patients with primary gastrointestinal MALT lymphoma at stage I–II and in 54.5 % of patients at stage III–IV (χ 2 = 3.882, p < 0.05). Average survival time in patients with p53 gene deletion was 8.0 months, being shorter than that of patients with normal p53 gene (32.81 months) (t = 3.609, p < 0.01). (3) ATM gene deletion was found in 23.8 % of patients with primary gastrointestinal MALT lymphoma; ATM gene deletion was found in 16.1 % of patients with primary gastrointestinal MALT lymphoma at stage I–II and in 45.5 % of patients at stage III–IV (χ 2 = 3.849, p < 0.05). Average survival time in patients with ATM gene deletion was 6.10 months, which is shorter than that of patients with normal ATM gene (31.71 months) (t = 3.503, p < 0.01). (4) IGH rearrangement, p53 and ATM gene deletion were no correlation with tumor location. (5) Average survival time in primary gastrointestinal MALT lymphoma patients of non-gene or single gene change was 33.42 months, which is longer than that of patients with multiple genes change (6.67 months) (t = 4.013,p < 0.01). There was a high incidence of IGH rearrangement or p53 and ATM gene deletion in patients at stage III–IV. The average survival time was shorter in these patients. Average survival time in primary gastrointestinal MALT lymphoma patients with multiple genes abnormalities was shorter than that in non-gene or single gene change patients. IGH rearrangement, p53 and ATM gene deletion may play a synergistic role in the occurrence and development of the primary gastrointestinal MALT lymphoma. Patients with multiple genes abnormalities had poor prognosis, and they should be advised early united chemotherapy.
Similar content being viewed by others
References
Psyrri A, Papageorgiou S, Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann Oncol. 2008;19:1992–9.
Thieblemont C. Clinical presentation and management of marginal zone lymphomas. Hematology Am Soc Hematol Educ Program. 2005;307–13.
Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract: report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961;49:80–9.
Musshoff K. Clinical staging classification of non-Hodgkin's lymphomas. Strahlentherapie. 1977;153:218–21.
Ye H, Liu H, Raderer M, et al. High incidence of t(11; 18) (q21; q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood. 2003;101:2547–50.
Streubel B, Lamprecht A, Dierlamm J, et al. T (14; 18) (q32; q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood. 2003;101:2335–9.
Shaoxu YING, Guowei LIN, Xiaohua LIANG, et al. Semi-nested PCR analysis of IgH-gene rearrangements in the diagnosis and follow-up of B-NHL. Shanghai Med J. 2002;25:51–5.
Yun-li HAN, Zhuang LIU, Hong-ying WEI, et al. Expressions of p16 and p53 in childhood with non-Hodgkin lymphoma. Guangxi Med J. 2008;30:957–9.
Du M, Peng H, Singh N, et al. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood. 1995;86(12):4587–93.
Venizelos I, Tamiolakis D, Bolioti S, et al. Primary MALT lymphomas of the stomach: a pathological study of 18 cases. Rev ESP Enferm Dig. 2007;99:270–4.
Yi TANG. ATM and cancer. J Exp Hematol. 2002;10:77–80.
Trbusek M, Malcikova J, Smardova J, et al. Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment. Leukemia. 2006;20:1159–61.
Caraway NP, Thomas E, Khanna A, et al. Chromosomal abnormalities detected by multicolor fluorescence in situ hybridization in fine-needle aspirates from patients with small lymphocytic lymphoma are useful for predicting survival. Cancer Cytopathol. 2008;114:315–22.
Conflicts of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, GP., Cao, PF. & Feng, LJ. Detection and clinical significance of genes in primary gastrointestinal MALT lymphoma. Tumor Biol. 35, 3223–3228 (2014). https://doi.org/10.1007/s13277-013-1421-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13277-013-1421-8